Navigation Links
Hoopes Vision Surgeon First in Utah to Implant New Light Adjustable Artificial Lens
Date:9/20/2013

SALT LAKE CITY, Sept. 20, 2013 /PRNewswire-iReach/ -- On September 4th Dr. Phillip C. Hoopes, Jr., a surgeon at Hoopes Vision, successfully placed a light adjustable intraocular lens implant in a cataract patient as part of a new FDA clinical study. The surgery, which took place at Hoopes Vision's on-site surgery center, EyeSurg of Utah, was the first of its kind to take place in Utah. Dr. Hoopes said, "It was an honor to be the first in our state to implant this revolutionary new lens. At Hoopes Vision, we always strive to bring the newest and most promising technology to patients here in Utah, and this lens may change the way cataracts are treated."

The Light Adjustable Lens (LAL®) is designed to be the world's first and only intraocular lens that allows surgeons to change the power of the lens after it has been implanted in the patient's eye during a cataract surgery procedure.

Cataract development is a normal part of aging and typically results in a clouding of the natural lens of the eye, thereby negatively affecting vision. This problem is solved by removing the cataract via a surgical procedure in which the cataract is replaced by a clear synthetic lens, referred to as an intraocular lens. Currently, no commercially available lens in the world has the ability to be adjusted after implantation in the eye, and therefore, many patients still need glasses after surgery for optimal vision. The LAL is designed to give patients excellent distance vision without the need for glasses.

The LAL is currently commercially available in Europe and Mexico. However, before the LAL can be made available to patients in the U.S. it must be approved for sale by the FDA. This requires completion of a series of clinical studies, the third and final phase of which has recently commenced. The study involves the treatment of 600 eyes at 15 investigative sites across the country.

Hoopes Vision is excited to be one of these exclusive sites currently enrolling patients for the phase III study and welcomes interest in participation from prospective patients. If you'd like more information and to determine if you might qualify for the study, please contact the Hoopes Vision Clinical Research Center at (801) 988-7342.

Caution: The LAL is an investigational device and is limited by United States federal law to investigational use only.

# # #

If you'd like more information, please call the Hoopes Vision Clinical Research Center at (801) 988-7342 or email research@hoopesvision.com.

Media Contact: Steve Linn, Hoopes Vision, (801) 988-7342, research@hoopesvision.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Hoopes Vision
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Deputy HHS Secretary, Investors and Entrepreneurs to Share Their Vision of Upcoming New Era in Health Care
2. VisionCare Ophthalmic Technologies Secures Up To $15MM To Accelerate Growth Of Its Novel Treatment For Age-Related Macular Degeneration
3. Hubble Telemedical Welcomes Healthcare Visionary Jonathan Lord, M.D. to Its Board of Directors
4. RainTree Oncology Expands Management As Strategic Vision For Community Oncology Unfolds
5. Users of PediaVisions Spot Vision Screener Honor Childrens Eye Health and Safety Month with Back-to-School Screenings
6. CRO Solutions, Inc. Announces Opening of New Division - VxP Pharma Services, Inc.
7. Dr. Sheldon Pinnell, The Founding Father Of Topical Antioxidants, Leading Scientist Behind SkinCeuticals, And Chief Emeritus Of The Division Of Dermatology At Duke University, Dies At 76
8. CMS Proposes Permanent Medicare Payment for VisionCares Telescope Implant for Macular Degeneration
9. Caradigm Provisioning Helps Healthcare Organizations Improve Clinical Efficiency, Manage Risk
10. New Vision Hope For Millions Undergoing Cataract Surgery
11. Industry Veteran, John Maroney, to Join ForSight VISION5 as President and CEO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... GUIYANG, China , 23. Februar 2017 ... Area , eine nationale Wirtschaftszone in der südwestlichen chinesischen Provinz ... Beschleunigung der Errichtung einer Innovationsplattform aktiv an der Entwicklung einer ... Continue Reading ... ...
(Date:2/23/2017)... Calif. , Feb. 23, 2017 ... leading the discovery and development of innovative medicines targeting ... full year 2016 financial results on Thursday, March 2, ... host a conference call and webcast on March 2, ... quarter and full year 2016 financial results and provide ...
(Date:2/23/2017)... , Feb 23, 2017 ... Research and Markets has announced the ... Industry Forecast to 2025" report to their offering. ... of around 1.8% over the next decade to reach approximately $12.8 billion ... estimates and forecasts for all the given segments on global as well ...
Breaking Medicine Technology:
(Date:2/23/2017)... ... (PRWEB) ... opportunity for the nation to come together to combine its ... – with its favorite fruit – apples! To celebrate National ... to join the “Apple Madness” bracket tournament – a five-week, ...
(Date:2/23/2017)... CA (PRWEB) , ... February 23, 2017 , ... Top ... Smiling Patriot program today with a new Indiegogo campaign . Individuals ... to homeless veterans in the Los Angeles area, either as a participating patient or ...
(Date:2/23/2017)... ... ... HealthPostures, the desk for standing designer headquartered in Prior Lake, Minnesota has ... Home and Garden Show which is being held February 24 through 26 and March ... Minneapolis Convention Center. , From its broad line of sit stand desk solutions, ...
(Date:2/23/2017)... CHURCH, Va. (PRWEB) , ... February 23, 2017 , ... ... worries, or problems. He has also continued to spiritually evolve, which is the purpose ... published book “ Our Spiritual Truths ” (published by Balboa Press) attempts to guide ...
(Date:2/22/2017)... ... February 22, 2017 , ... Our high-octane society ... even the sharpest brain. , Power On, a mental performance enhancer from Modus ... the brain. Each capsule contains Cognizin® Citicoline, a branded form of the brain ...
Breaking Medicine News(10 mins):